🚨 New webinar alert! 🚨Join us Feb 12 at 16:00 UTC for an important webinar on care for patients with immune-mediated iTTP. This session kicks off a new webinar series based on the 2025 update to the International Society on Thrombosis and Haemostasis TTP Guidelines.
👉 Register: bit.ly/3ZGsyCQ
👉 Register: bit.ly/3ZGsyCQ
January 29, 2026 at 4:29 PM
🚨 New webinar alert! 🚨Join us Feb 12 at 16:00 UTC for an important webinar on care for patients with immune-mediated iTTP. This session kicks off a new webinar series based on the 2025 update to the International Society on Thrombosis and Haemostasis TTP Guidelines.
👉 Register: bit.ly/3ZGsyCQ
👉 Register: bit.ly/3ZGsyCQ
The @fda.gov has expanded the approval of Cablivi® to include treatment of pediatric patients 12 years and older with #aTTP, in combination with plasma exchange and immunosuppressive therapy. From @medicalprofref.bsky.social.
https://bit.ly/4aTlSbu
#TTPawareness #iTTP #thrombosis
https://bit.ly/4aTlSbu
#TTPawareness #iTTP #thrombosis
Cablivi Approved for Pediatric Acquired Thrombotic Thrombocytopenic Purpura
The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.
bit.ly
January 15, 2026 at 8:48 PM
The @fda.gov has expanded the approval of Cablivi® to include treatment of pediatric patients 12 years and older with #aTTP, in combination with plasma exchange and immunosuppressive therapy. From @medicalprofref.bsky.social.
https://bit.ly/4aTlSbu
#TTPawareness #iTTP #thrombosis
https://bit.ly/4aTlSbu
#TTPawareness #iTTP #thrombosis
#Daratumumab is safe and effective in allowing patients with #iTTP to achieve ADAMTS13 remission. Presented at #ASH25.
https://bit.ly/48HbIb9
https://bit.ly/48HbIb9
December 11, 2025 at 3:47 PM
#Daratumumab is safe and effective in allowing patients with #iTTP to achieve ADAMTS13 remission. Presented at #ASH25.
https://bit.ly/48HbIb9
https://bit.ly/48HbIb9
Anti–CUB domain antibodies target residues Trp1250, Lys1252, and Arg1367 in patients with iTTP. buff.ly/TCQ27V8#heme...
November 2, 2025 at 3:30 PM
Anti–CUB domain antibodies target residues Trp1250, Lys1252, and Arg1367 in patients with iTTP. buff.ly/TCQ27V8#heme...
?ittp
November 1, 2025 at 11:10 AM
?ittp
La bande originale du jeu Earthion en double vinyle bleu est dispo en précommande
Fnac = edcol.fr/6iO4
+d'info sur le blog = edcol.fr/ITtP
#Earthion (lien affilié)
Fnac = edcol.fr/6iO4
+d'info sur le blog = edcol.fr/ITtP
#Earthion (lien affilié)
October 29, 2025 at 4:44 PM
La bande originale du jeu Earthion en double vinyle bleu est dispo en précommande
Fnac = edcol.fr/6iO4
+d'info sur le blog = edcol.fr/ITtP
#Earthion (lien affilié)
Fnac = edcol.fr/6iO4
+d'info sur le blog = edcol.fr/ITtP
#Earthion (lien affilié)
"In an apparent reference to last week’s presidential election, which saw Catherine Connolly TD win in a landslide, Mr Stirrup said Ireland’s “individual tailored partnership programme” (ITTP) with NATO “is coming increasingly under threat with recent political shifts in Irish leadership”.
October 28, 2025 at 7:08 PM
"In an apparent reference to last week’s presidential election, which saw Catherine Connolly TD win in a landslide, Mr Stirrup said Ireland’s “individual tailored partnership programme” (ITTP) with NATO “is coming increasingly under threat with recent political shifts in Irish leadership”.
kynnys.fi/tule-kokemaa... ITTP tänään Turussa! Tervetuloa!
Tule kokemaan integroidun tanssin ja teatterin huumaa! – Kynnys ry
Integroidun tanssin- ja teatterin päivä 2025 Tule mukaan Integroidun tanssin ja teatterin päivään 4.10. klo 17-20 Turun BARKER-teatterilla (os. Linnankatu 31, 20100 Turku, 4. krs.). Luvassa on jälleen...
kynnys.fi
October 4, 2025 at 9:02 AM
kynnys.fi/tule-kokemaa... ITTP tänään Turussa! Tervetuloa!
Kto miałby oceniać Nie znam takiego kogoś Jestem przeciwnikiem cenzury.
Pobyt może być i na treści np kłamstwo Oświęcimskie ittp... jak też trzeba koniecznie cenzurować treści pedofilskie itp nie możemy tego puścić samopas bo jest pobyt.... tak myślę i prawodawstwo w tym kierunku podąża
Pobyt może być i na treści np kłamstwo Oświęcimskie ittp... jak też trzeba koniecznie cenzurować treści pedofilskie itp nie możemy tego puścić samopas bo jest pobyt.... tak myślę i prawodawstwo w tym kierunku podąża
October 2, 2025 at 7:43 PM
Kto miałby oceniać Nie znam takiego kogoś Jestem przeciwnikiem cenzury.
Pobyt może być i na treści np kłamstwo Oświęcimskie ittp... jak też trzeba koniecznie cenzurować treści pedofilskie itp nie możemy tego puścić samopas bo jest pobyt.... tak myślę i prawodawstwo w tym kierunku podąża
Pobyt może być i na treści np kłamstwo Oświęcimskie ittp... jak też trzeba koniecznie cenzurować treści pedofilskie itp nie możemy tego puścić samopas bo jest pobyt.... tak myślę i prawodawstwo w tym kierunku podąża
Tule kokemaan integroidun tanssin ja teatterin huumaa!
ITTP 4.10. klo 17-20, Turun BARKER-teatterille. Os. Linnankatu 31, 4 krs. Turku. Tapahtuma on maksuton ja esteetön.
ITTP 4.10. klo 17-20, Turun BARKER-teatterille. Os. Linnankatu 31, 4 krs. Turku. Tapahtuma on maksuton ja esteetön.
September 9, 2025 at 3:34 PM
Tule kokemaan integroidun tanssin ja teatterin huumaa!
ITTP 4.10. klo 17-20, Turun BARKER-teatterille. Os. Linnankatu 31, 4 krs. Turku. Tapahtuma on maksuton ja esteetön.
ITTP 4.10. klo 17-20, Turun BARKER-teatterille. Os. Linnankatu 31, 4 krs. Turku. Tapahtuma on maksuton ja esteetön.
Early intervention with plasma exchange, steroids, and rituximab boosts iTTP survival to 93%, but caplacizumab raises bleeding risk.
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/article-abstract/2834159
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/article-abstract/2834159
August 21, 2025 at 6:39 PM
Early intervention with plasma exchange, steroids, and rituximab boosts iTTP survival to 93%, but caplacizumab raises bleeding risk.
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/article-abstract/2834159
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/article-abstract/2834159
Repukes want to have sex with 10 year olds are groups of pedophlles they want ittp take away women's rights voting take it back 1920!
August 17, 2025 at 5:16 PM
Repukes want to have sex with 10 year olds are groups of pedophlles they want ittp take away women's rights voting take it back 1920!
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review. ja.ma/3H9b4tv
Learn more in this Review. ja.ma/3H9b4tv
August 12, 2025 at 3:20 PM
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review. ja.ma/3H9b4tv
Learn more in this Review. ja.ma/3H9b4tv
ADAMTS13's conformational regulation is crucial for enzymatic function & pathophysiology of thrombotic thrombocytopenic purpura. Open ADAMTS13 has emerged as a novel biomarker for acute & subclinical iTTP, aiding in prediction of early relapses during patient follow-up 👉https://bit.ly/40BpoS2
#TTP
#TTP
August 12, 2025 at 9:02 AM
ADAMTS13's conformational regulation is crucial for enzymatic function & pathophysiology of thrombotic thrombocytopenic purpura. Open ADAMTS13 has emerged as a novel biomarker for acute & subclinical iTTP, aiding in prediction of early relapses during patient follow-up 👉https://bit.ly/40BpoS2
#TTP
#TTP
Congratulations 👏👏 to @mimrobert.bsky.social for this very nice work 🗞
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP
Anti-ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post-TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen.
onlinelibrary.wiley.com
July 16, 2025 at 7:10 PM
Congratulations 👏👏 to @mimrobert.bsky.social for this very nice work 🗞
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
📰 #iTTP is a rare disease that primarily affects individuals aged 20-40 years. Authors show results indicate caplacizumab is effective in reducing refractoriness, risk of death & likelihood of exacerbations in elderly patients, similar to outcomes observed in younger patients 👉https://bit.ly/42h2a4H
July 16, 2025 at 11:01 AM
📰 #iTTP is a rare disease that primarily affects individuals aged 20-40 years. Authors show results indicate caplacizumab is effective in reducing refractoriness, risk of death & likelihood of exacerbations in elderly patients, similar to outcomes observed in younger patients 👉https://bit.ly/42h2a4H
Thanks to everyone who contributed to the annual Integrative Toxicology Training Partnership (ITTP) Summer School at the MRC Toxicology Unit. It was an excellent week spent sharing knowledge and building networks in toxicology.
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
July 16, 2025 at 8:55 AM
Thanks to everyone who contributed to the annual Integrative Toxicology Training Partnership (ITTP) Summer School at the MRC Toxicology Unit. It was an excellent week spent sharing knowledge and building networks in toxicology.
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
July 5, 2025 at 2:00 PM
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
If I post the stupid ITTP photo enough with the dumb Fiszi version of Henry in it that shock hates enough, maybe she'll redraw it for me with the proper versions of them.
June 2, 2025 at 9:26 AM
If I post the stupid ITTP photo enough with the dumb Fiszi version of Henry in it that shock hates enough, maybe she'll redraw it for me with the proper versions of them.
JAMA CME review of Immune Thrombotic Thrombocytopenic Purpura (iTTP) - thrombotic microangiopathy w/ hemolytic anemia (MAHA) & thrombocytopenia. iTTP incidence is 2-6 per million. Caused by Abs to ADAMTS13), w/ low ADAMTS13 activity vWF multimers bind platelets buff.ly/zwIbVCF
May 30, 2025 at 4:30 AM
JAMA CME review of Immune Thrombotic Thrombocytopenic Purpura (iTTP) - thrombotic microangiopathy w/ hemolytic anemia (MAHA) & thrombocytopenia. iTTP incidence is 2-6 per million. Caused by Abs to ADAMTS13), w/ low ADAMTS13 activity vWF multimers bind platelets buff.ly/zwIbVCF
Survival rates for patients with iTTP soar to 93% with prompt treatment, though bleeding risk and relapses persist.
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
May 28, 2025 at 4:39 PM
Survival rates for patients with iTTP soar to 93% with prompt treatment, though bleeding risk and relapses persist.
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
JAMA CME review of Immune Thrombotic Thrombocytopenic Purpura (iTTP) - thrombotic microangiopathy w/ hemolytic anemia (MAHA) & thrombocytopenia. iTTP incidence is 2-6 per million. Caused by Abs to ADAMTS13), w/ low ADAMTS13 activity vWF multimers bind platelets edhub.ama-assn.org/jn-learning/...
edhub.ama-assn.org
May 26, 2025 at 4:03 PM
JAMA CME review of Immune Thrombotic Thrombocytopenic Purpura (iTTP) - thrombotic microangiopathy w/ hemolytic anemia (MAHA) & thrombocytopenia. iTTP incidence is 2-6 per million. Caused by Abs to ADAMTS13), w/ low ADAMTS13 activity vWF multimers bind platelets edhub.ama-assn.org/jn-learning/...
Listen to coauthor Allyson Pishko of @upenn.edu discuss this review of iTTP with JAMA Associate Editor David Simel.
edhub.ama-assn.org/jn-learning/...
edhub.ama-assn.org/jn-learning/...
Immune Thrombotic Thrombocytopenic Purpera (iTTP)
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare coagulopathic disorder characterized by immune-mediated thrombocytopenia and microangiopathic hemolytic anemia, that can cause life-threatening thrombosis. Coauthor Allyson M. Pishko, MD, MSCE, of the University of Pennsylvania joins JAMA Associate Editor David Simel, MD, MHS, to discuss the recent review of iTTP published in JAMA.
edhub.ama-assn.org
May 19, 2025 at 4:14 PM
Listen to coauthor Allyson Pishko of @upenn.edu discuss this review of iTTP with JAMA Associate Editor David Simel.
edhub.ama-assn.org/jn-learning/...
edhub.ama-assn.org/jn-learning/...
Immune thrombotic thrombocytopenic purpura (iTTP) is an immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia.
Learn more in this Review. https://ja.ma/4kc5qF1
Learn more in this Review. https://ja.ma/4kc5qF1
May 19, 2025 at 4:00 PM
Immune thrombotic thrombocytopenic purpura (iTTP) is an immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia.
Learn more in this Review. https://ja.ma/4kc5qF1
Learn more in this Review. https://ja.ma/4kc5qF1